baber/WOPTO huggingface dataset:
Patent CA-2458735-A1 (CA)
Title: Antenna for cellular phone
Inventor: KIM YOUN SUNG
IPC: H01Q1/24
Filed: 2004-02-25
Abstract: The present invention relates to an antenna for a cellular phone that is always installed in the same construction irrespective of an outer look of an antenna when the antenna is engaged to a cellular phone body, and is stably fixed to a cellular phone body, and an assembling and disassembling procedure are easy, and an antenna exchanging operation is conveniently performed. The antenna for a cellular phone comprises an antenna holder having a guide groove part and engaged in a body of a cellular phone; an antenna housing that is formed of an antenna connector having a protrusion part engaged to the guide groove part and fixedly inserted into the antenna holder, and an antenna support part integrally formed in the antenna connector; and a rod antenna that passes through the antenna connector and the antenna support part, respectively, in such a manner that the rod antenna is extendable from the body of the cellular phone.
Patent CA-2459149-A1 (CA)
Title: Tibial prosthesis
Inventor: HELDRETH MARK A
IPC: A61F2/38
Filed: 1994-05-02
Abstract: A modular tibial prosthesis contains a dovetail mechanism (4, 5 & 14) and a posterior tongue (15) and groove (8) arrangement. The dovetail mechanism cooperates with a reinforcing component (22) to allow alternate use of a spined component (20) with the same base plate (1).
Patent CA-2459492-A1 (CA)
Inventor: KIDO HIROSHI
IPC: A61P43/00
Filed: 2002-09-03
Abstract: Anti-influenza drugs containing as the active ingredient ambroxol, bromhexine or pharmacologically acceptable salts thereof. Namely, remedies or preventives for influenza characterized by having an anti-influenza effect via the promotion of the secretion of a biological anti-influenza virus factor contained in the airway fluid. These drugs are characterized by inhibiting the growth of an influenza virus in the airway by promoting the secretion of an inhibitor for a protease in the airway which induces the infectivity of the influenza virus. These drugs are also characterized by inhibiting the growth of an influenza virus in the airway by promoting the secretion of mucosal immunity substances IgA and IgG. These drugs are further characterized by inhibiting the release of inflammatory cytokines in the airway.
Patent CA-2461081-A1 (CA)
Title: Optical monitor module
Inventor: MORI KEIICHI
IPC: G02B6/42
Filed: 2004-03-15
Abstract: In one half portion of one surface 11a of a substrate 11 there are formed in parallel V grooves 14 1 and 14 2 of the same depth, in which optical fibers 21 and 22 are disposed and positioned with their axes held at a height H1 with respect to the surface 11a. The optical fibers 21 and 22 have lens portions 21 a and 22a formed integrally therewith at one end, and the end faces of the lens portions 21 a and 22a are tilted at an angle .theta.' from their axes. A beam sputter 31 is mounted on the substrate 11 on a center line 25 between elongations of the optical fibers 21 and 22, and light emitted from the lens portion 21 a propagates through space and is launched in focused form into the beam sputter 31, and a portion of the incident light is reflected, which propagates space and is launched in focused form into the lens portion 22a and propagates through the optical fiber 22. The light having passed through the beam splitter 31 is launched into a light receiving element 32. By monitoring an electrical signal that is output from the light receiving element 32, it is possible to monitor the light propagating through the optical fiber 22.
Patent CA-2461154-A1 (CA)
Title: Gaming device having bonus game terminator that activates a mechanical device
Inventor: WEBB BAYARD S
IPC: G07F17/32
Filed: 2002-09-16
Abstract: A gaming machine (10a) having a bonus game wherein a mechanical device (100) is activated upon termination of the bonus game to select a bonus modifier (102). This modifier is used to determine the player~s final bonus award.
Patent CA-2464258-A1 (CA)
Inventor: SHAH SYED MUZAFAR
IPC: A61K31/496
Filed: 2004-04-08
Abstract: An aminocarboxylic acid chelating agent, preferably EDTA, or a salt thereof has been found to be useful for inhibiting particulate formation in piperacillin/tazobactam parenteral combinations. The composition may also contain a buffer, preferab ly citrate, and optionally an aminoglycoside. The product. may be in the form o f a frozen composition that can be thawed far use. The product may also be in the form of a cryodesiccated powder than can be reconstituted by addition of an aqueous vehicle to reform a solution.
Patent CA-2466093-A1 (CA)
Title: Interior trim component and method of forming same
Inventor: SYED JOSEPH OMAR
IPC: B32B7/12
Filed: 2002-10-31
Abstract: An interior trim component (10) is formed utilizing an injection molding apparatus having first (12) and second (14) molds. The component includes a laminate (16) and a polymer (18). The laminate (16) includes a face layer (2 0) having a finished (26) and unfinished (28) side, an adhesive layer (22) bond ed to the unfinished side (28), and a barrier (24) bonded to the adhesive layer (22). The barrier (24) includes a non-woven textile weighing at least 80 g/m 2. The laminate (16) is positioned in the first mold (12) such that the barrier (24) is exposed to face the second mold (14). The apparatus is moved into a closed position and a cavity (30) is established between the barrier (24) an d the second mold (14). The polymer (18) is injected into the cavity (30) at a pressure of at least 500 psi. The polymer reacts with the barrier (24) to bo nd the laminate (16) to the polymer (18) and to form the interior trim componen t (10) without the polymer (18) penetrating through the barrier (24) and into the face layer (20).
Patent CA-2466896-A1 (CA)
Title: Procede et kit de diagnostic destines a la selection et/ou detection qualitative et/ou quantitative de cellules
Inventor: STEFFENS PIA
IPC: G01N33/569
Filed: 2002-05-17
Abstract: L'invention concerne un procédé de sélection et/ou de détection qualitative et/ou quantitative de cellules biologiques prédéfinies issues de ou contenues dans un échantillon renfermant des cellules biologiques. L'échantillon est mélangé à une association prédéfinie d'au moins deux anticorps et/ou dérivés d'anticorps qui, de préférence, se lient par leurs sites de liaison à différents épitopes des cellules à sélectionner ou à détecter, et/ou à au moins un anticorps et/ou un dérivé d'anticorps biospécifique, qui se lie, de préférence, par ses deux sites de liaison à différents épitopes des cellules à sélectionner ou à détecter. Les cellules marquées par au moins un anticorps et/ou un dérivé d'anticorps sont séparées de l'échantillon et les cellules séparées sont vérifiées par une association prédéfinie d'au moins deux réactifs de détection de biologie moléculaire. Les deux agents de détection ou plus, de préférence, réagissent avec au moins un constituant des cellules à sélectionner ou à détecter.
Patent CA-2467864-A1 (CA)
Inventor: KENDON MICHAEL
IPC: G06F19/00
Filed: 2002-11-22
Abstract: A method of securely storing and accessing personal data (26) relating to an individual (28), said personal data constituting a personal data record, is described. The method comprises: coupling a portable data storage device (42) to a computing device (12) for data transfer between them, the storage device carrying an encrypted personal data record (38) and a decryption means (40) for decrypting the personal data record upon provision of a key (36) not stored on the storage device (42); accessing the personal data record on the storage device (42) and running the decryption means (40) on the computing device (12) to decrypt the personal data record upon input of the key (36) to the computing device; and displaying the decrypted personal data (26) by means of the computing device.
Patent CA-2470068-A1 (CA)
Title: Textured surface having undercut micro recesses in a surface
Inventor: AMRICH MARK
IPC: A61F2/32
Filed: 2002-12-12
Abstract: Textured surface (12) having micro recesses (20) such that the outer surface overhangs the micro recesses. Embodiments of the textured surface include sharp edges for promoting bone deposition and growth within the micro recesses, protrusions of varying depth from the surface that include overhangs, and micro recesses that are at least partially defined by complex ellipsoids.
Patent CA-2470126-A1 (CA)
Title: Constant velocity rappelling device with braking device
Inventor: ANGERMANN GEROLD
IPC: A62B1/10
Filed: 2002-10-31
Abstract: The invention relates to an abseiling device comprising a rope guide pulley (2) which is rotationally mounted in a housing (1) and is connected by a toothed wheel (4) to two toothed shafts (5, 5') of centrifugal power braking elements comprising pairs of brake blocks (8, 8') acting on the device housing (8, 8') and comprising brake boots (10, 10') and additional safety brake boots (10"). The brake blocks of each pair are maintained in a rest position by means of a magnet (11) and an iron core (11'), which are disposed in the opposite front sides (8") of the brake blocks.
Patent CA-2473311-A1 (CA)
Title: Radiateur independant
Inventor: BRISTOW GARY
IPC: F24C7/00
Filed: 2003-01-09
Abstract: L'invention se rapporte à un radiateur indépendant comprenant un logement (4) comportant une paroi arrière (8) et une paroi frontale (10). Un moyen d'effet combustible solide (12) est placé à l'avant de la paroi frontale. Des moyens de chauffage sont installés de manière classique. Un moyen d'effet flammes est suspendu à l'intérieur du logement (4) par un support supérieur (30), ledit moyen se présentant, dans le mode de réalisation préféré, sous la forme d'une feuille de matériau souple et léger, la feuille étant dotée d'ouvertures allongées (20). Des moyens (18) ont pour effet de faire bouger la feuille (14), notamment par l'intermédiaire d'un flux d'air dirigé vers le haut contre le matériau, ce qui cause l'ondulation de ce dernier. De la lumière est dirigée depuis une source lumineuse (28) contre le moyen d'effet flammes, une partie de la lumière étant directement réfléchie par le moyen d'effet flammes à travers un écran translucide (24), une partie de la lumière passant à travers des ouvertures (20) ménagées dans la feuille (14) et étant dirigée sur un réflecteur (32) puis réfléchie par le réflecteur pour repasser à travers la feuille (14) et l'écran (24).
Patent CA-2474171-A1 (CA)
Title: Biphenil derivatives and their use as antiandrogenic agents
Inventor: LUU-THE VAN
IPC: A61P17/14
Filed: 2003-02-14
Abstract: Biphenyl derivatives are disclosed for use in the treatment of androgen- dependent diseases such as prostate cancer, benign prostatic hyperplasia, precicious puberty, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and premature male baldness. For example, some preferred compounds having the structure (formula I): are formulated together with pharmaceutically acceptable diluent or carrier for topical use in the treatment of androgen-dependent prostate cancer.
Patent CA-2474225-A1 (CA)
Inventor: SEO KANG SOO
IPC: G11B27/32
Filed: 2003-08-21
Abstract: Selon la présente invention, un support d'enregistrement possède une structure de données permettant de gérer la reproduction de données vidéo à plusieurs voies de reproduction enregistrées sur ledit support d'enregistrement. Ce dernier comprend une zone de données stockant au moins une partie des données vidéo à plusieurs voies de reproduction. Celles-ci sont divisées en au moins une unité d'entrelacement, et chaque unité d'entrelacement est associée à une des voies de reproduction. Chaque unité d'entrelacement commence et se termine avec un point de changement de voie de reproduction, et les unités d'entrelacement associées aux différences voies de reproduction sont entrelacées dans la zone de données.
Patent CA-2474481-A1 (CA)
Title: Procede de mise en oeuvre d'un ordinateur et/ou d'un reseau informatique en vue de distribuer des produits biotechnologiques
Inventor: RHODES MICHAEL
IPC: C12Q1/68
Filed: 2002-10-30
Abstract: L'invention concerne un procédé destiné à distribuer un produit à un consommateur et consistant à utiliser un réseau informatique pour interagir avec le consommateur en vue d'obtenir des informations comprenant au moins une séquence d'acides nucléiques cible, et à fournir une séquence amorce avant, une séquence amorce inverse et une séquence sonde présentant des caractéristiques spécifiées, la séquence amorce avant et la séquence amorce inverse définissant ensemble une séquence amplicon, l'amplicon se trouvant dans la séquence d'acides nucléiques, la séquence sonde étant complémentaire d'une partie de la séquence amplicon. Ledit procédé consiste ensuite à fabriquer un produit d'analyse comprenant une amorce avant selon la séquence amorce avant, une amorce inverse selon la séquence amorce inverse et une sonde selon la séquence sonde, à valider l'une au moins de l'amorce avant, de l'amorce inverse et de la sonde, puis à distribuer le produit d'analyse à un consommateur.
Patent CA-2475539-A1 (CA)
Inventor: SLEEP DARRELL
IPC: A61P17/06
Filed: 2003-02-07
Abstract: The invention relates to proteins comprising HIV fusion inhibiting peptides, such as T-20 and/or T-1249 peptides (including, but not limited to, fragment s and variants thereof), which exhibit anti-retroviral activity, fused to albumin (including, but nbot limited to fragments or vairants of albumin). These fusion proteins are herein collectively referred to as "albumin fusion proteins of the invention." These fusion proteins exhibit extended shelf-lif e and/or extended or therapeutic activity. The invention encompasses therapeut ic albumin fusion proteins, compositions, pharmaceutical compositions, formulations and kits. The invention also encompasses nucleic acid molecules encoding the albumin fusion proteins of the invention, as well as vectors containing these nucleic acids, host cells transformed with these nucleic acids and vectors, and methods of making the albumin fusion proteins of the invention using these nucleic acids, vectors, and/or host cells. The inventi on also relates to compositions and methods for inhibiting HIV-induced cell fusion. The invention further relates to compositions and methods for inhibiting HIV transmission to uninfected cells.
Patent CA-2477019-A1 (CA)
Title: Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
Inventor: YANG LIPING
IPC: A61K31/366
Filed: 2003-02-26
Abstract: The present invention relates to a use of total coumarins of cnidium fruit in preparation of a medicament for treating psoriasis. The total coumarins of the invention can improve the clinical symptom of psoriasis, have higher curative effect and are safe to use. It can be administrated both externally and orally.
Patent CA-2479551-A1 (CA)
Title: Optical sorting method
Inventor: SEPP ARMIN
IPC: C12Q1/6811
Filed: 2000-01-06
Abstract: The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of:  (a) compartmentalizing genetic elements into microcapsules; (b) expressing the genetic elements to produce their respective gene products within the microcapsules;  (c) sorting the genetic elements which produce the gene product having the desired activity using a change in the optical properties of the genetic elements. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative application of the method of the invention.
Patent CA-2481532-A1 (CA)
Inventor: HIRANO MISATO
IPC: A61P29/00
Filed: 2003-04-02
Abstract: L'invention concerne un composé représenté par la formule (I) dans laquelle R?1¿ est un atome d'hydrogène, un groupe alkyl etc., R?2¿ est un atome d'hydrogène, un atome halogène etc., R?3¿ est un atome d'hydrogène, un groupe alkyl etc., R?4¿ est un groupe aryl etc., A est un aryl?1¿ etc., B est un alkylène etc., et X est NH etc., ou un ester pharmaceutiquement acceptable d'un tel composé et des sels pharmaceutiquement acceptables dudit composé ou ester. Les composés selon l'invention servent au traitement de troubles médicaux à médiation par prostaglandine, tels que la douleur, la fièvre ou les inflammations. L'invention concerne également une composition pharmaceutique contenant lesdits composés.
Patent CA-2483568-A1 (CA)
Title: Method of reducing hydrolysis in hydrocarbon streams
Inventor: EATON PAUL EUGENE
IPC: C10G17/00
Filed: 2003-04-28
Abstract: A method of reducing hydrolysis in a hydrocarbon stream comprising adding to a hydrocarbon stream containing a chloride compound which undergoes hydrolysis at elevated temperatures in the presence of water to form hydrochloric acid, an effective amount of a treating agent that is at least one overbased complex of a metal salt and an organic acid complexing agent, the treating agent being added to hydrocarbon stream when the stream is at a temperature below which any substantial hydrolysis of the chloride containing compound occurs.
Patent CA-2484355-A1 (CA)
Title: System and method for transformation of xml documents using stylesheets
Inventor: JONES KEVIN J
IPC: G06F15/00
Filed: 2003-05-02
Abstract: A method and apparatus are provided for creating and abstract machine instruction sequence from one or more stylesheets (12) and using this sequence to perform a transformation on one or more input documents (20). The method includes the steps of parsing the stylesheet and compiling it into the sequence of abstract machine instructions. The instructions are executed an the abstract machine (18) with input document(s) (20) to produce one or more output documents (22). More particularly, the method is directed to processing one or more XML documents (20) where the processing includes a plurality of stylesheets (12) using an abstract machine (18). The method includes the steps of reading a stylesheet (14) of the plurality of stylesheet (12), compiling the stylesheet (16) into a set of abstract machine instructions specialized for stylesheet processing and executing the instructions on the abstract machine (18).
Patent CA-2485775-A1 (CA)
Inventor: LUETHI MARKUS
IPC: B42D15/00
Filed: 2004-10-22
Abstract: The invention relates to a packaging material with a forgery-proof security feature, whereby the security feature comprises a coded image arrangement (2) which is provided on the packaging material and which reveals an image or image sequence by superimposing a related decoder element (4). The invention is characterised in that the decoder element (4) is a transparent or translucent, film-type object with a line or column-type pattern (5) made up of lines or columns lined up parallel to each other specific distances apart, and the image arrangement (2) on the packaging material contains a plurality of coded individual images that mix into each other, whereby the coded individual image is an arrangement of strip-shaped image elements (3) that are spaced apart and are co-ordinated in terms of orientation and distance from each other with respect to the line or column pattern (5) of the decoder element (4), such that by overlapping the image arrangement (2) and the decoder element (4) and lateral displacement of the decoder element (4) over the image arrangement (2), an image sequence that to the human eye appears to be moving is obtained and, depending on the position of the decoder element (4) the coded individual images are covered or are visible by means of the window regions lying between the lines or columns and, in combination with the line or column-type pattern (5) of the decoder element (4), fit together to make up recognisable images (7a-f).
Patent CA-2487193-A1 (CA)
Inventor: DOHERTY JOHN A
IPC: A01G25/09
Filed: 1997-11-18
Abstract: An apparatus and system is disclosed, preferably mounted on a service vehicle, for synchronized application of fluid materials, either solid or liquid, to a vehicle travel surface in proportional amounts or spatially distributed proportions in response to user defined requirements and/or operation of a vehicle mounted component in response to conditions encountered in real time. A first embodiment is a vehicle mounted apparatus and system for coordinated application of a plurality of materials to a surface simultaneously and in desired proportions and/or widths automatically and/or selectively. A second embodiment includes a granular material distribution device and includes a plurality of liquid spray headers and pumping means. A third embodiment includes an automated component control such as blade blocking plate control based on sensed current surface condition information and current accurate location information as well as past operating history and predicted near term weather conditions.
Patent CA-2487339-A1 (CA)
Inventor: HESS WERNER
IPC: C09J7/21
Filed: 2003-06-10
Abstract: This invention relates to an adhesive tape comprising a knitted or woven substrate having weft yarns and a layer of adhesive coated onto the substrate.  The substrate is closed to substantially prevent the passage of adhesive through it.
Patent CA-2489874-A1 (CA)
Inventor: LEYBACH HOLGER
IPC: C09C1/00
Filed: 2003-06-16
Abstract: L'invention concerne des structures planes-parallèles de silicium/oxyde de silicium (flocons de silicium/oxyde de silicium) pouvant être obtenues par chauffage de structures planes-parallèles de SiO¿y? dans une atmosphère exempte d'oxygène, à une température supérieure à 400 ·C, avec 0,70 = y = 1,8. Dans un autre mode de réalisation, l'invention concerne des structures planes-parallèles de silicium/oxyde de silicium pouvant être obtenues par chauffage de structures planes-parallèles de SiO¿x? dans une atmosphère exempte d'oxygène, à une température supérieure à 400 ·C, avec 0,03 = x = 0,95. L'invention concerne également un procédé de fabrication desdites structures et leur utilisation dans la fabrication de pigments d'interférence.
Patent CA-2491455-A1 (CA)
Title: Nouvelle utilisation d'imidazotriazinones
Inventor: NIEWOEHNER MARIA
IPC: A61P27/06
Filed: 2003-06-24
Abstract: La présente invention concerne de nouvelles utilisations d'imidazo[1,2,4]triazinones pour produire un médicament servant à traiter et/ou à prévenir des maladies coronariennes, des insuffisances cardiaques, une hypertension pulmonaire, des maladies vésicales, une hyperplasie prostatique, une tolérance induite par nitrate, des maladies oculaires, telles que le glaucome, à traiter et/ou à prévenir une occlusion artérielle rétinienne centrale ou ciliaire postérieure, une occlusion veineuse rétinienne centrale, une neuropathie optique, telle qu'une neuropathie optique ischémique antérieure et une neuropathie optique glaucomateuse, ainsi qu'une dégénérescence maculaire, des diabètes, notamment la gastroparésie diabétique, à traiter des troubles péristaltiques de l'estomac et du tube digestif, une stérilité féminine, des contractions prématurées, une prééclampsie, une alopécie, un psoriasis du syndrome rénal, une fibrose kystique, des cancers, à améliorer la perception, à améliorer le pouvoir de concentration et à améliorer la faculté d'apprentissage et/ou de mémorisation, notamment lorsque le trouble résulte d'une démence.